IL6 and COVID-19: Wilson et al. [68] evaluated plasma of hospitalized COVID-19 patients and segregated them according to the severity of the disease; they found that mild cases presented a significant upregulation of miR-150-5p, and they also found an upregulation of IL-6 in severe cases when compared with mild and moderate ones.